Fate Therapeutics Inc XNAS: FATE

Download real time

1.06 -0.05 (-4.50%)

45.36% Fall from 52W High

1.5M

XNAS Volume

XNAS 08 Jan, 2026 4:30 PM (EST)

Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 12 analysts

Fate Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -53.3%, and profit growth estimate of 26.7% for FY25, based on top 12 analyst calls.

Forecaster Screeners